Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Baricitinib is effective as a treatment for severe hair loss.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Transcutol-containing vesicles improve minoxidil's skin penetration and hair growth promotion.

The treatment improved hair color in most vitiligo patients without major side effects.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

Tectoridin helps human hair cells grow and makes mouse hair longer, suggesting it could treat hair loss.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

The FDA approved a new Pfizer drug for hair loss in teens.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Targeting blood vessels may help treat skin diseases.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The 7.5% talok and 2% pare leaf extract hair tonic effectively promotes hair growth, similar to minoxidil.